CONFERENCES
Scientific Sessions
PHA Canada is pleased to invite Canada’s health care providers to the 7th National Pulmonary Hypertension Scientific Sessions (formerly known as the Medical Think Tank). Join us in Vancouver on September 24–25, 2026, for an opening reception, a full day of research and practice updates, and an engaging community discussion.
​
The event will be preceded by an invitation-only meeting of the Canadian Pulmonary Hypertension Research Network (CaPH-NET), with invitations distributed separately.
​
This national interdisciplinary meeting has become an annual must-attend educational and scientific event for medical professionals who treat and support patients with pulmonary hypertension, as well as others working in respiratory and heart health.
This accredited event is of special interest to those in our clinical and scientific community, including adult and pediatric respirologists, cardiologists, nurse practitioners, pharmacists, physician assistants, medical students and residents, fellows and trainees, graduate students, nurses, clinical fellows, and researchers.
We look forward to seeing you in Vancouver!
Scientific Sessions 2026:
September 24 – 25, 2026
Sheraton Vancouver Airport Hotel
Vancouver, BC
Connect & Learn Program
Consider joining us on the evening of Thursday, September 24, for the separately ticketed Welcome Reception: Connect & Learn opening panel (6:15-7:00 PM) and dinner (7:00-9:00 PM).
​
Download the Thursday evening program and look for the Welcome Reception: Connect & Learn add-on when you register to secure your ticket.
​
Scientific Sessions Program​
“High yield content, with each talk short and focused” – event participant, 2025
Come prepared for a full, intense day of learning!
​
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Thoracic Society. You may claim a maximum of 6.5 hours.
​
​
The program features two keynote presentations:
-
The role of inflammation in pulmonary arterial hypertension
Dr. Stephen Archer & Dr. Patricia Lima, Queen’s University -
Disentangling the central, peripheral and hematological mechanisms of benefit from sotatercept
Dr. Yogesh Reddy, MBBS, MSc, Mayo Clinic
Other topics in this year’s program (subject to change):
-
Exploring integrin a5B1 as a Potential Therapeutic Target for PAH
-
Endothelial Senescence as a Therapeutic Target in PAH
-
Spotting CTEPH
-
The Hemodynamics and Pulmonary Vascular Physiology of Group 4 PH
-
Pulmonary Vascular Recruitment During Exercise
-
Looking further into pulmonary vascular structure and function with quantitative lung imaging
-
Seeing the Right Heart: AI-Derived RV Function and PH Screening from Standard Echocardiography
-
Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in PAH
-
Targeting Cancer-Like Endothelial Cell Growth in PAH Using CAR-NK Cell Immunotherapy
-
The nexus between the vasculature and fibrosis – innovations in Group 3 PH
-
Update on porto-pulmonary hypertension
​
The program is co-developed by the Pulmonary Hypertension Association of Canada and the Canadian Thoracic Society and is planned to achieve scientific integrity, objectivity, and balance.
​
In conjunction with PHA Canada’s 2026 Pulmonary Hypertension Community Conference.​
Pricing
Welcome Reception: Connect & Learn
Welcome Reception: Connect & Learn: Thursday, September 24, 2026 (5pm - 9pm)
Kick off the conference by joining colleagues for an evening of connection, conversation, and clinical insight. This welcoming reception and dinner offer a relaxed setting to network with peers, and begin engaging with key topics that will shape the day ahead. The evening will also feature a fireside chat on transitioning from pediatric to adult care designed to spark discussion and set the stage for a meaningful and collaborative conference experience.
$50.00
Scientific Sessions 2026
Scientific Sessions 2026: Friday, September 25, 2026
MD/PhD
$375.00
Allied Health Professional & Trainee
$225.00
Industry Representative
$1,500.00
Virtual ticket (attend full day via Zoom)
$75.00
Accommodations:
Sheraton Vancouver Airport Hotel
7551 Westminster Highway
Richmond, BC
V6X 1A3
604-273-7878
​
There is a group rate available, click here to learn more
Learning objectives
After attending the program, participants will be able to:
-
Realize the importance of a comprehensive assessment for pulmonary hypertension patients so they are diagnosed quickly and accurately.
-
Summarize the most effective treatment approaches for the various types of pulmonary hypertension.
-
Review the current landscape of, and future directions for, basic and translational research on pulmonary hypertension.
Our Sponsors
PLATINUM
GOLD
SILVER
BRONZE
SUPPORTERS
